Daniel E. Beck
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
Publications
18
Citations
355
Est. group size
~8
Recurring co-author estimate
Active years
38
Publishing since 1989
Daniel E. Beck's research focuses on designing and studying small molecules that target cancer-related proteins, particularly enzymes called topoisomerases that help cells copy their DNA. This work involves synthesizing new chemical compounds and testing how their structure relates to their biological activity, with the goal of developing potential cancer treatments.
Publication output was minimal or absent in the mid-2010s to early 2020s but has increased noticeably since 2022, suggesting a recent growth in research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors
Molecular Cancer Therapeutics · 2018
- Investigation of the Structure–Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons
Journal of Medicinal Chemistry · 2016
- Alzheimer s & Dementia×5
- Journal of Medicinal Chemistry×2
- Molecular Cancer Therapeutics×1
- Alzheimer s & Dementia Translational Research & Clinical Interventions×1
- Bioorganic & Medicinal Chemistry×1
- Xiaoming Wang
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Mark Cushman
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Peter J. Blanco Carcache
Pharmacology, Toxicology and Pharmaceutics · The Ohio State University
- Jack C. Yalowich
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Chelsea A. Mann
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile